Immuno-Oncology Add-On Trials: More May Not Be Better, US FDA Cautions

Oncology developers should ensure clinical development plans involving early-stage trials adding on to perioperative treatment regimens will show that new therapies are adding benefit in each phase, Oncology Center of Excellence Director Richard Pazdur said.